Unbound MEDLINE

Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.

Abstract

PURPOSE
Molecular events underlying progression of well-differentiated liposarcoma (WDLS) to dedifferentiated liposarcoma (DDLS) are poorly defined. This study sought to identify copy number alterations (CNA) associated with dedifferentiation of WDLS, with DDLS morphology, and with patient outcomes.
EXPERIMENTAL DESIGN
Fifty-five WDLS and 52 DDLS were analyzed using Agilent 244K comparative genomic hybridization and Affymetrix U133A expression arrays. CNAs were identified by RAE analysis. Thirty-nine of the DDLS specimens were categorized morphologically by a single pathologist.
RESULTS
Nine regions of CNA were identified as recurrent in DDLS but not WDLS; 79% of DDLS had at least one of these CNAs. Loss of the chromosome segment 11q23-24, the most common event, was observed only in DDLS that morphologically resembled the genomically complex sarcomas, undifferentiated pleomorphic sarcoma and myxofibrosarcoma. 11q23-24 loss was itself associated with increased genomic complexity in DDLS. Loss of 19q13, but not 11q23-24, was associated with poor prognosis. Median disease-specific survival was shorter for patients with19q13 loss (27 months) than for patients with diploid 19q13 (>90 months; P < 0.0025), and 19q13 loss was associated with local recurrence (HR, 2.86; P = 0.013). Common copy number losses were associated with transcriptional downregulation of potential tumor suppressors and adipogenesis-related genes (e.g., EI24 and CEBPA).
CONCLUSIONS
Dedifferentiation of WDLS is associated with recurrent CNAs in 79% of tumors. In DDLS, loss of 11q23-24 is associated with genomic complexity and distinct morphology whereas loss of 19q13 predicts poor prognosis. CNAs in liposarcoma improve risk stratification for patients and will help identify potential tumor suppressors driving liposarcoma progression.

Links

  • PMC Free PDF
  • Publisher Full Text
  • Authors

    Crago AM, Socci ND, DeCarolis P, O'Connor R, Taylor BS, Qin LX, Antonescu CR, Singer S

    Institution

    Sarcoma Disease Management Program, Department of Surgery, Bioinformatics Core, Computational Biology Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

    Source

    Clinical cancer research : an official journal of the American Association for Cancer Research 18:5 2012 Mar 1 pg 1334-40

    MeSH

    Adult
    Aged
    Aged, 80 and over
    Chromosomes, Human, Pair 11
    Chromosomes, Human, Pair 19
    DNA Copy Number Variations
    Disease Progression
    Female
    Genes, Tumor Suppressor
    Genomic Instability
    Humans
    Liposarcoma
    Male
    Middle Aged
    Prognosis
    Risk Factors
    Survival Analysis
    Young Adult

    Pub Type(s)

    Journal Article
    Research Support, N.I.H., Extramural
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22241790